Gene and Cell Therapy: Development and Commercialization Summit
June 05, 2019 ‐ June 06, 2019 in Berlin, Germany
The Gene and Cell Therapy: Development and Commercialization Summit will be held from June 5 - 6, 2019 in Berlin, Germany.
Stephan Reynier M. Sc., Chief Regulatory and Compliance Officer at Cellectis, will participate in this event through a case study presentation titled, "Case Study: Challenges and Opportunity of Gene-Edited CAR T-cells" on June 5.